南通大学学报(医学版)

参考文献

[1]　L lewelynJG.The diabetic neuropathies:types,diagnosis andmanagement.JNeurolNeurosurgPsychiatry[J].2003,74Sup-pl2∶ ii15.

[2]　VerrottiA,GiuvaPT,MorgeseG,et al.New trends in the e-tiopathogenesis of diabetic peripheral neuropathy[J].J ChildN eurol,2001,16(6)∶389.

[3]　GryzEA,Galicka-LatalaD,SzczudlikA,et al.Etiopatho-genesis of diabetic neuropathyPrzeglLek[J].2000,57(12)∶727.

[4]　VerrottiA,GiuvaPT,MorgeseG,et al.New trends in the e-tiopathogenesis of diabetic peripheral neuropathy[J].J ChildN eurol,2001,16(6)∶389.

[5]　SimaAA,Sugim otoK.Experimental diabetic neuropathy:anupdate[J].Diabetologia,1999,42(7)∶773.

[6]　KryvkoIuIa,Kozyts' kyiZIa,SerhiienkoOO,et al.Diabeticneuropathies.Metabolism of sorbitol in sciatic nerve tissue instreptozotocin diabetes[J].UkrBiokhimZh,2001,73(5)∶69.

[7]　ChungSS,HoEC,LamKS,etal.Contribution of polyol path-way to diabetes-induced oxidative stress[J].J AmSocN ephrol,2003,14(8Suppl3)∶S233.

[8]　OatesPJ.Polyol pathway and diabetic peripheral neuropathy[J].IntRevNeurobiol,2002,50∶325.

[9]　GreeneDA,ArezzoJC,BrownMB.Effect of aldose reductaseinhibition on nerve conduction and m orphome in diabetic neu-ropathy[J].ZenarestatStudyGroup.N eurology,1999,53(3)∶580.

[10]　ObrosovaIG,VanHuysenC,FathallahL ,et al.An aldosereductase inhibitor reverses early diabetes-induced changesin peripheral nerve function,metabolism,and antioxidativedefense[J].F ASEB J,2002,16(1)∶123.

[11]　NakamuraJ,HamadaY,ChayaS,et al.Transition metals andpolyol pathway in the development of diabetic neuropathy inrats[J].DiabetesMetabResRev,2002,18(5)∶395

[12]　SuzenS,BuyukbingolE.Recent studies of aldose reductaseenzyme inhibition for diabetic complications[J].CurrMedChem,2003,10(15)∶1329.

[13]　VinikAI.Diabetic neuropathy:pathogenesis and therapy[J].AmJ Med,1999,30∶107(2B)∶17S.

[14]　刘　欣,康德萱.糖尿病神经病变发生机制研究的若干进展[J].国外医学神经病学神经外科学分册,2001,28(3)∶201.

[15]　ZochodneDW.Diabetic neuropathies:features and mecha-nisms[J].BrainPathol,1999,9(2)∶369.

[16]　WeiswasserJM,AroraS,ShumanC,et al.Diabetic neuropa-thy[J].SeminVascSurg,2003,16(1)∶27.

[17]　ObrenovichME,MonnierVM.VitaminB1blocks damagecaused by hyperglycemia[J].SciSAGE KE,2003,12(10)∶PE6.

[18]　ZhuXP,ZhouZG.Clinical observation of combined therapeu-tic effect of prostaglandinE1and mecobalamin on diabetic pe-ripheral neuropathy[J].H unanYiK eDaX ueXueBao,2001,26(4)∶343.

[19]　YagihashiS,Pathology of diabetic neuropathy;a review fromthe updated literature of the last10 years[J].N ipponRinsho,2002,60Suppl10∶204.

[20]　ZochodneDW,ChengC.Diabetic peripheral nerves are sus-ceptible to multifocal ischemic damage from endothelin[J].BrainRes,1999,838(1-2)∶11.

[21]　CameronNE,EatonSE,CotterMA,et al.Vascular factorsand metabolic interactions in the pathogenesis of diabetic neu-ropathy[J].Diabetologia,2001,44(11)∶1973.

[22]　ApfelSC.Neurotrophic factors in peripheral neuropathies:therapeutic implications[J].BrainPathol,1999,9(2)∶393.

[23]　何　成.神经营养因子的神经修复作用及其机制[J].中国神经科学杂志,2002,18(1)∶466.

[24]　YasudaH,TeradaM,MaedaK,etal.Diabetic neuropathy andnerve regeneration[J].ProgN eurobiol,2003,69(4)∶229.

[25]　ApfelSC.Nerve growth factor for the treatment of diabeticneuropathy:what went wrong,what went right,and whatdoes the future hold?[J]IntRevN eurobiol,2002,50∶393.

[26]　SayersNM,BeswickLJ,MiddlemasA,etal.Neurotrophin-3prevents the proximal accumulation of neurofilament proteinsin sensory neurons of streptozocin-induced diabetic rats[J].Diabetes,2003,52(9)∶2372.

[27]　SimmonsZ,Feldm anEL .Update on diabetic neuropathyCurrOpinNeurol[J].2002,15(5)∶3595.